Strategy, marketing, and commercial execution for healthcare technology companies.
Your FDA review clock runs about four months. Your reimbursement clock runs closer to two years. Here is how to sequence the work.
FDA clearance is often the fastest step in a device launch, not the longest. Coding, coverage, and evidence run on clocks you do not control. Learn how to build a launch schedule backward from your expected clearance date.
Read Post →
In most health systems a committee, not your physician champion, decides whether your device gets bought. Learn the four questions it asks and the six-part dossier that gets a decision instead of a deferral.
Read Post →
FDA clearance lets you sell. Reimbursement decides whether anyone pays. Learn the three questions every payer answer must resolve, and what the new RAPID pathway changes.
Read Post →
Physicians trust peers, not ads. Learn how to map real clinical influence, sustain KOL relationships, and turn credibility into adoption and revenue.
Read Post →
FDA clearance is a milestone, not a finish line. Learn why 75% of MedTech companies fail to scale after clearance and what a proven commercialization strategy actually looks like.
Read Post →We work with commercially-viable health technology companies that are ready to scale. If that sounds like you, let's talk.
Schedule a Call